Should the FDA reconsider antidepressant boxed warnings?

UC expert featured in Medscape article

The University of Cincinnati's Jeffrey Strawn, MD, spoke with Medscape about whether the Food and Drug Administration should reevaluate boxed warnings on antidepressants linking the medications to an increased risk for suicidal thoughts and behaviors in young people.

The warnings have been in place for almost two decades, but evidence suggests they may have led to fewer depression diagnoses, reduced prescriptions and higher suicide rates.

Strawn said there was not as much data on the risks and benefits of antidepressants in youth when the warnings were instituted, but the current evidence suggests it's time to reevaluate the warnings. 

“I don’t think that they’ve been useful. They’ve actually been harmful,” Strawn, professor in the Department of Psychiatry and Behavioral Neuroscience in UC’s College of Medicine and a UC Health child and adolescent psychiatrist, told Medscape Medical News. “These boxed warnings have decreased physicians’ and other clinicians’ comfort and tendency to prescribe.”

Read the Medscape article.

Featured photo at top of medication spilling out of a bottle with a warning symbol in the background. Photo/Arthit Pornpikanet/iStock.

Related Stories

1

CCM welcomes new film and media scoring faculty member J.R. Paredes

May 20, 2026

UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of J.R. Paredes as CCM's new Assistant Professor of Film and Media Scoring. His faculty appointment officially begins on Aug. 15, 2026. Paredes is a composer, music producer and audio post-production specialist whose work spans film, television and commercial music. His credits include original scores for feature films and series distributed on platforms such as Apple TV+ and Prime Video, as well as extensive work in sound design and mixing for film and media.

2

6 ways starting a GLP-1 medication could affect your emotions

May 20, 2026

When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.